References
- American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 1987; 136: 225–244
- ten Brinke A, Zwinderman A H, Sterk P J, Rabe K F, Bel E H. Factors associated with persistent airflow limitation in severe asthma. Am J Respir Crit Care Med 2001; 164: 744–748, [PUBMED], [INFOTRIEVE], [CSA]
- Parker D R, O'Connor G T, Sparrow D, Segal M R, Weiss S T. The relationship of nonspecific airway responsiveness and atopy to the rate of decline of lung function. Am Rev Respir Dis 1990; 141: 589–594, [PUBMED], [INFOTRIEVE]
- O'Connor G T, Sparrow D, Weiss S T. A prospective longitudinal study of methacholine airway responsiveness as a predictor of pulmonary‐function decline: the normative aging study. Am J Respir Crit Care Med 1995; 152: 87–92, [PUBMED], [INFOTRIEVE], [CSA]
- Tracey M, Villar A, Dow L, Coggon D, Lampe F C, Holgate S T. The influence of increased bronchial responsiveness, atopy and serum IgE on decline in FEV1. Am J Respir Crit Care Med 1995; 151: 656–662, [PUBMED], [INFOTRIEVE], [CSA]
- Rijcken B, Schouten J P, Xu X, Rosner B, Weiss S T. Airway hyperresponsiveness to histamine associated with accelerated decline in FEV1. Am J Respir Crit Care Med 1995; 151: 1377–1382, [PUBMED], [INFOTRIEVE]
- Standardization of spirometry—1994 update: statement of the American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107–1136
- Standardized lung function testing: official statement of the European Respiratory Society. Eur Respir J 1993; 6(suppl. 16)1–100
- Crapo R O, Morris A H, Gardner R M. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am Rev Respir Dis 1981; 123: 659–664, [PUBMED], [INFOTRIEVE]
- Goldman H I, Becklake M R. Respiratory function tests; normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 1959; 79: 457–467, [PUBMED], [INFOTRIEVE]
- American Thoracic Society. Guidelines for methacholine and exercise challenge testing—1999. Am J Respir Crit Care Med 2000; 161: 309–329, [CSA]
- Litonjua A A, Sparrow D, Weiss S T. The FEF25–75/FVC ratio is associated with methacholine airway responsiveness. Am J Respir Crit Care Med 1999; 159: 1574–1579, [PUBMED], [INFOTRIEVE], [CSA]
- O'Connor G, Sparrow D, Taylor D, Segal M, Weiss S T. Analysis of dose‐response curves to methacholine. An approach suitable for population studies. Am Rev Respir Dis 1987; 136: 1412–1417, [PUBMED], [INFOTRIEVE]
- National Heart, Lung and Blood Institute. Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. Publication No. 97–4051, National Institute of Health, Bethesda, MD 1997; 1–4
- Nelson H S. β‐adrenergic bronchodilators. N Engl J Med 1995; 333: 499–506, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Johnson M. The β‐adrenoceptor. Am J Respir Crit Care Med 1998; 158: S146–S153, [PUBMED], [INFOTRIEVE], [CSA]
- Davis P B, Simpson D M, Paget G L, Turi V. Beta‐adrenergic response in drug‐free subjects with asthma. J Allergy Clin Immunol 1986; 77: 871–879, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Nielson C P, Crowley J J, Vestal R E, Connolly M J. Impaired beta‐adrenoceptor function, increased leukocyte respiratory burst, and bronchial hyperresponsiveness. J Allergy Clin Immunol 1992; 90: 825–832, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Connolly M J, Crowley J J, Nielson C P, Charan N B, Vestal R E. Relationship between nonspecific bronchial responsiveness to methacholine and peripheral mononuclear leukocyte beta‐adrenergic receptor function in young drug‐naive subjects. Am Rev Respir Dis 1992; 146: 592–597, [PUBMED], [INFOTRIEVE]
- Elsasser S, Donna E, Demirozu C M, Danta I, Wanner A. Metaproterenol responsiveness after methacholine‐ and histamine‐induced bronchoconstriction. Chest 1996; 110: 617–623, [PUBMED], [INFOTRIEVE]
- Reishaus E, Innis M, MacIntyre N, Liggett S B. Mutations in the gene encoding for the β2‐adrenergic receptor in normal and asthmatic subjects. Am J Respir Cell Mol Biol 1993; 8: 334–339
- Holroyd K J, Levitt R C, Dragwa C, Amelung P J, Panhuysen C M, Meyers D A. Evidence for β2‐adrenergic receptor polymorphism at amino acid 16 as a risk factor for bronchial hyperresponsiveness. Am J Respir Crit Care Med 1995; 151: A673
- Green S A, Turki J, Innis M, Ligget S B. Amino‐terminal polymorphisms of the human β2‐adrenergic receptor impart distinct agonist‐promoted regulatory properties. Biochemistry 1994; 33: 9414–9419, [PUBMED], [INFOTRIEVE]
- Ramsay C E, Hayden C M, Tiller K J, Burton P R, Goldblatt J, Lesouef P N. Polymorphisms in the β2‐adrenoreceptor gene are associated with decreased airway responsiveness. Clin Exp Allergy 1999; 29: 1195–1203, [PUBMED], [INFOTRIEVE], [CROSSREF]